ZNF582 and cervical carcinoma: In the market, there are also two CE-marked tests for the detection of cervical cancer (Cervi-M®) and oral cancer (Oral-M®) by analyzing PAX1 and ZNF582 gene methylation in cervix smears and oral epithelial cells [110,111].